Cardiac Fibrosis and Remodeling
Cardiac Fibrosis and Remodeling is a research topic within Cardiology and Cardiovascular Medicine. Science Explorer counts 19k research works in it since 1951. 25.1% of them reached the world's top 10% most cited for their field and year.
This cluster of papers explores the molecular mechanisms underlying cardiac remodeling and repair, focusing on the inflammatory response, myocardial infarction, fibrosis, hypertrophy, macrophage involvement, extracellular matrix dynamics, and the role of cytokines in heart failure.
- Cardiac Remodeling
- Inflammatory Response
- Myocardial Infarction
- Fibrosis
- Hypertrophy
- Macrophages
- Extracellular Matrix
- Tumor Necrosis Factor
- Cytokines
- Heart Failure
- Research works
- 19k fractional, since 1951
- In the world top 10%
- 4.8k per year above
- Top-10% rate
- 25.1% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +11% the tick is no change
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Cardiac Fibrosis and Remodeling research?
By volume, China and the United States publish the most (1.4k and 721 works in 2022–2025).
By volume, 2022–2025
- 1 China 1.4k works
- 2 United States 721 works
- 3 Germany 173 works
- 4 Japan 117 works
- 5 United Kingdom 103 works
- 6 Italy 84 works
- 7 Spain 69 works
- 8 India 68 works
- 9 Canada 67 works
- 10 France 61 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Cardiac Fibrosis and Remodeling research?
By volume in 2022–2025, Chinese Academy of Medical Sciences & Peking Union Medical College publishes the most Cardiac Fibrosis and Remodeling research, followed by Nanjing Medical University and Wuhan University.
By volume, 2022–2025
- 1 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 41 works
- 2 Nanjing Medical UniversityChina 24 works
- 3 Wuhan UniversityChina 18 works
- 4 Washington University in St. LouisUnited States 17 works
- 5 Capital Medical UniversityChina 17 works
- 6 Shanghai Jiao Tong UniversityChina 16 works
- 7 Huazhong University of Science and TechnologyChina 15 works
- 8 Sun Yat-sen UniversityChina 14 works
- 9 Renmin Hospital of Wuhan UniversityChina 14 works
- 10 Shanghai University of Traditional Chinese MedicineChina 13 works
Who are the leading researchers in Cardiac Fibrosis and Remodeling?
The most-cited researchers publishing on Cardiac Fibrosis and Remodeling include Robert O. Bonow and Hugo A. Katus.
- 1 Robert O. Bonow United States 4.5k citations
- 2 Hugo A. Katus Germany 3.8k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Cardiac Fibrosis and Remodeling research done?
The largest centres of Cardiac Fibrosis and Remodeling research in 2022–2025 are Beijing (China), Shanghai (China), Guangzhou (China) and Nanjing (China). Among places with at least 20 works in it, it is an unusually large share of all research in Shijiazhuang.
Largest cities, 2022–2025
Where it is the local speciality
- ShijiazhuangCN · 22.8 works6.3×
Location quotient: how much more of its research is in Cardiac Fibrosis and Remodeling than the world average.
Where is the best place to study Cardiac Fibrosis and Remodeling?
Among universities, judged by research, Chinese Academy of Medical Sciences & Peking Union Medical College, Albert Einstein College of Medicine and Beijing University of Chinese Medicine score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina | 67.1 | 33.7% | 12.2× | 41 | -0.6% |
| 2 | Albert Einstein College of MedicineUnited States | 65.9 | 43.5% | 19.6× | 13 | +36.0% |
| 3 | Beijing University of Chinese MedicineChina | 63.1 | 33.1% | 21.1× | 13 | +368.5% |
| 4 | Guangzhou University of Chinese MedicineChina | 63.0 | 33.1% | 18.7× | 12 | +275.4% |
| 5 | Wuhan UniversityChina | 60.1 | 41.8% | 4.2× | 18 | +210.0% |
| 6 | Nanjing Medical UniversityChina | 59.8 | 31.0% | 13.7× | 24 | +40.3% |
| 7 | Medizinische Hochschule HannoverGermany | 58.4 | 43.3% | 11.9× | 9 | -3.4% |
| 8 | Nanjing University of Chinese MedicineChina | 57.6 | 37.4% | 12.6× | 11 | +86.1% |
| 9 | Wenzhou Medical UniversityChina | 56.5 | 34.7% | 8.2× | 10 | +250.1% |
| 10 | Shanxi Medical UniversityChina | 49.9 | 29.4% | 13.7× | 10 | +80.7% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Cardiac Fibrosis and Remodeling research growing?
Output in 2018–2022 was 11% higher than in 2013–2017, peaking in 2025. The fastest-growing topics are Cardiac Fibrosis and Remodeling.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.